Cargando…
Efficacy and safety of topical ganciclovir in the management of cytomegalovirus (CMV)-related anterior uveitis
BACKGROUND: The aim of this study was to evaluate the efficacy and safety of topical ganciclovir 0.15 % gel in the management of patients with cytomegalovirus (CMV) anterior uveitis. RESULTS: This was a retrospective cohort study of the disease course of 31 patients (33 eyes) with aqueous polymerase...
Autores principales: | Wong, John X. H., Agrawal, Rupesh, Wong, Elizabeth P. Y., Teoh, Stephen C. |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Springer Berlin Heidelberg
2016
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4791412/ https://www.ncbi.nlm.nih.gov/pubmed/26976016 http://dx.doi.org/10.1186/s12348-016-0078-z |
Ejemplares similares
-
Efficacy and safety of an extemporaneous preparation of 2% ganciclovir eye drops in CMV anterior uveitis
por: Keorochana, Narumon, et al.
Publicado: (2017) -
Long-Term Outcome of Treatment with 2% Topical Ganciclovir Solution in Cytomegalovirus Anterior Uveitis and Corneal Endotheliitis
por: Chen, Po-Jui, et al.
Publicado: (2022) -
Ganciclovir-resistant CMV (GCV-R CMV) Infection Leads to Poor Clinical Outcomes and Economic Burden of Ganciclovir-resistant Cytomegalovirus Infection in Lung Transplant Recipients
por: Patel, Twisha, et al.
Publicado: (2017) -
Immune recovery uveitis in HIV patients with cytomegalovirus retinitis in the era of HAART therapy—a 5-year study from Singapore
por: Yeo, Tun Hang, et al.
Publicado: (2016) -
Resolution of Mild Ganciclovir-Resistant Cytomegalovirus Disease with Reduced-Dose Cidofovir and CMV-Hyperimmune Globulin
por: Patel, Samir J., et al.
Publicado: (2014)